Gian Luigi Cetto

1.8k total citations
59 papers, 1.1k citations indexed

About

Gian Luigi Cetto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gian Luigi Cetto has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Gian Luigi Cetto's work include Lung Cancer Research Studies (12 papers), Breast Cancer Treatment Studies (11 papers) and Lung Cancer Treatments and Mutations (10 papers). Gian Luigi Cetto is often cited by papers focused on Lung Cancer Research Studies (12 papers), Breast Cancer Treatment Studies (11 papers) and Lung Cancer Treatments and Mutations (10 papers). Gian Luigi Cetto collaborates with scholars based in Italy, United States and United Kingdom. Gian Luigi Cetto's co-authors include Annamaria Molino, Andrea Bonetti, Giuseppe Pelosi, Rocco Micciolo, Rolando Nortilli, Franco Bonetti, Quirino Piubello, Monica Turazza, Felice Pasini and Marta Zaninelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gian Luigi Cetto

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gian Luigi Cetto Italy 19 666 369 290 199 183 59 1.1k
Farhat Ben Ayed Tunisia 17 594 0.9× 382 1.0× 385 1.3× 170 0.9× 163 0.9× 54 1.2k
Vincenzo Sforza Italy 18 680 1.0× 194 0.5× 380 1.3× 173 0.9× 362 2.0× 58 1.2k
Henrik Hellborg Sweden 18 667 1.0× 355 1.0× 337 1.2× 111 0.6× 293 1.6× 24 1.2k
Alan Barge United Kingdom 14 819 1.2× 166 0.4× 411 1.4× 179 0.9× 250 1.4× 21 1.5k
H. C. Falkson South Africa 16 608 0.9× 349 0.9× 174 0.6× 138 0.7× 199 1.1× 32 1.0k
K. Gunnarsdóttir Denmark 9 774 1.2× 461 1.2× 477 1.6× 132 0.7× 221 1.2× 14 1.2k
Marzia Locatelli Italy 17 757 1.1× 535 1.4× 329 1.1× 131 0.7× 221 1.2× 36 1.2k
Henrica M.J. Werner Norway 22 330 0.5× 259 0.7× 471 1.6× 127 0.6× 183 1.0× 58 1.4k
Bradley G. Somer United States 16 808 1.2× 279 0.8× 412 1.4× 192 1.0× 304 1.7× 45 1.3k
Timothy F. Wozniak United States 8 736 1.1× 408 1.1× 195 0.7× 84 0.4× 224 1.2× 16 967

Countries citing papers authored by Gian Luigi Cetto

Since Specialization
Citations

This map shows the geographic impact of Gian Luigi Cetto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Luigi Cetto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Luigi Cetto more than expected).

Fields of papers citing papers by Gian Luigi Cetto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gian Luigi Cetto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Luigi Cetto. The network helps show where Gian Luigi Cetto may publish in the future.

Co-authorship network of co-authors of Gian Luigi Cetto

This figure shows the co-authorship network connecting the top 25 collaborators of Gian Luigi Cetto. A scholar is included among the top collaborators of Gian Luigi Cetto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Luigi Cetto. Gian Luigi Cetto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Genestreti, Giovenzio, Melissa Frizziero, Marcella De Maglie, et al.. (2011). Carboplatin and Gemcitabine in First-Line Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer: Data from a Retrospective Study. Journal of Chemotherapy. 23(4). 232–237. 4 indexed citations
2.
Ferla, Rita, Luis Del Valle, Sergio Piña‐Oviedo, et al.. (2009). Leptin and Its Receptor are Overexpressed in Brain Tumors and Correlate with the Degree of Malignancy. Brain Pathology. 20(2). 481–489. 53 indexed citations
3.
Fiorio, Elena, Anna Mercanti, Marianna Terrasi, et al.. (2008). Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivoanalysis. BMC Cancer. 8(1). 305–305. 94 indexed citations
4.
Molino, Annamaria, Monica Giovannini, A. Auriemma, et al.. (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Critical Reviews in Oncology/Hematology. 59(3). 226–233. 49 indexed citations
5.
Santo, Antonio, Giovenzio Genestreti, Alberto Terzi, et al.. (2006). Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients. Lung Cancer. 53(3). 355–360. 6 indexed citations
6.
Santo, Antonio, Giovenzio Genestreti, Teodoro Sava, et al.. (2006). Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC). Annals of Oncology. 17. v55–v61. 8 indexed citations
7.
Nortilli, Rolando, et al.. (2006). Chemotherapy for metastatic melanoma. Expert Review of Anticancer Therapy. 6(1). 121–130. 23 indexed citations
8.
Nicolato, A., Roberto Foroni, Franco Alessandrini, et al.. (2005). Gamma Knife Radiosurgery in Brain Metastases from Testicular Tumors. Medical Oncology. 22(1). 45–56. 7 indexed citations
9.
Roila, F., Enzo Ballatori, L. Patoia, et al.. (2003). Adjuvant systemic therapies in women with breast cancer:an audit of clinical practice in Italy. Annals of Oncology. 14(6). 843–848. 26 indexed citations
10.
Santo, Antonio, Rebecca Pedersini, Felice Pasini, et al.. (2001). A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis. Lung Cancer. 34. 15–20. 13 indexed citations
11.
Nortilli, Rolando, Savina Aversa, Adriano Paccagnella, et al.. (2001). Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients. Melanoma Research. 11(2). 189–196. 53 indexed citations
12.
Molino, A., Michele Pavarana, Rocco Micciolo, et al.. (2000). Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers. Annals of Oncology. 11(5). 581–586. 18 indexed citations
13.
Pasini, Felice, Gian Luigi Cetto, & Giuseppe Pelosi. (1998). Does bone marrow involvement affect prognosis in small-cell lung cancer?. Annals of Oncology. 9(3). 247–250. 8 indexed citations
14.
Molino, Annamaria, Giuseppe Pelosi, Monica Turazza, et al.. (1997). Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis. Breast Cancer Research and Treatment. 42(1). 23–30. 55 indexed citations
15.
Bonetti, Andrea, Marta Zaninelli, Stefania Rodella, et al.. (1996). Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma. Breast Cancer Research and Treatment. 38(3). 289–297. 43 indexed citations
16.
Molino, A., Rocco Micciolo, Monica Turazza, et al.. (1995). Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methods. Breast Cancer Research and Treatment. 34(3). 221–228. 29 indexed citations
17.
Molino, Annamaria, Monica Turazza, Andrea Bonetti, et al.. (1992). Estrogen and Progesterone Receptors in Breast Cancer: Correlation with Clinical and Pathological Features and with Prognosis. Oncology. 49(2). 82–88. 15 indexed citations
18.
Feruglio, Cristina, Renato Zambello, Livio Trentin, et al.. (1992). Cytotoxic In vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy effects of activation with recombinant interleukin-2. Cancer. 69(10). 2525–2531. 5 indexed citations
19.
Campora, Elisabetta, Cristina Oliva, Serafina Mammoliti, et al.. (1991). Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient. Breast Cancer Research and Treatment. 19(2). 129–132. 7 indexed citations
20.
Cetto, Gian Luigi, et al.. (1983). Empiric Therapy of Infections in Hematologic Malignancies: A Prospective, Randomized Trial. Tumori Journal. 69(2). 155–160. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farhat Ben Ayed Breakdown of academic impact, for papers by Vincenzo Sforza Breakdown of academic impact, for papers by Henrik Hellborg Breakdown of academic impact, for papers by Alan Barge Breakdown of academic impact, for papers by H. C. Falkson Breakdown of academic impact, for papers by K. Gunnarsdóttir Breakdown of academic impact, for papers by Marzia Locatelli Breakdown of academic impact, for papers by Henrica M.J. Werner Breakdown of academic impact, for papers by Bradley G. Somer Breakdown of academic impact, for papers by Timothy F. Wozniak
Rankless by CCL
2026